280 related articles for article (PubMed ID: 24625330)
1. Fibrin sealants: surgical hemostat, sealant and adhesive.
Mandell SP; Gibran NS
Expert Opin Biol Ther; 2014 Jun; 14(6):821-30. PubMed ID: 24625330
[TBL] [Abstract][Full Text] [Related]
2. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of a new autologous fibrin sealant.
Alston SM; Solen KA; Sukavaneshvar S; Mohammad SF
J Surg Res; 2008 May; 146(1):143-8. PubMed ID: 18279893
[TBL] [Abstract][Full Text] [Related]
4. Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis.
Daud A; Kaur B; McClure GR; Belley-Cote EP; Harlock J; Crowther M; Whitlock RP
Eur J Vasc Endovasc Surg; 2020 Sep; 60(3):469-478. PubMed ID: 32620348
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.
Lowe J; Luber J; Levitsky S; Hantak E; Montgomery J; Schiestl N; Schofield N; Marra S;
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):323-31. PubMed ID: 17505437
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
7. A Prospective, Randomized, Multicenter Clinical Trial on the Safety and Efficacy of a Ready-to-Use Fibrin Sealant as an Adjunct to Hemostasis during Vascular Surgery.
Chetter I; Stansby G; Sarralde JA; Riambau V; Giménez-Gaibar A; MacKenzie K; Acín F; Navarro-Puerto J;
Ann Vasc Surg; 2017 Nov; 45():127-137. PubMed ID: 28647631
[TBL] [Abstract][Full Text] [Related]
8. Role of fibrin sealants in liver surgery.
de Boer MT; Boonstra EA; Lisman T; Porte RJ
Dig Surg; 2012; 29(1):54-61. PubMed ID: 22441621
[TBL] [Abstract][Full Text] [Related]
9. Fibrin sealants in clinical practice.
Albala DM
Cardiovasc Surg; 2003 Aug; 11 Suppl 1():5-11. PubMed ID: 12869982
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts.
Saha SP; Muluk S; Schenk W; Dennis JW; Ploder B; Grigorian A; Presch I; Goppelt A
J Vasc Surg; 2012 Jul; 56(1):134-41. PubMed ID: 22633423
[TBL] [Abstract][Full Text] [Related]
11. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.
Saif R; Jacob M; Robinson S; Amer A; Kei-Hui D; Sen G; Manas D; White S
Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):131-41. PubMed ID: 21654294
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis.
Turner AS; Parker D; Egbert B; Maroney M; Armstrong R; Powers N
J Biomed Mater Res; 2002; 63(1):37-47. PubMed ID: 11787027
[TBL] [Abstract][Full Text] [Related]
13. Dural repair with four spinal sealants: focused review of the manufacturers' inserts and the current literature.
Epstein NE
Spine J; 2010 Dec; 10(12):1065-8. PubMed ID: 21094467
[TBL] [Abstract][Full Text] [Related]
14. The use of hemostatic agents and sealants in urology.
Hong YM; Loughlin KR
J Urol; 2006 Dec; 176(6 Pt 1):2367-74. PubMed ID: 17085103
[TBL] [Abstract][Full Text] [Related]
15. Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study.
Massin P; Scemama C; Jeanrot C; Boyer P
Orthop Traumatol Surg Res; 2012 Apr; 98(2):180-5. PubMed ID: 22405589
[TBL] [Abstract][Full Text] [Related]
16. Prevention of suture hole bleeding using fibrin sealant: benefits of factor XIII.
Dickneite G; Metzner H; Nicolay U
J Surg Res; 2000 Oct; 93(2):201-5. PubMed ID: 11027461
[TBL] [Abstract][Full Text] [Related]
17. Fibrin sealant in the United States: clinical use at the University of Virginia.
Spotnitz WD
Thromb Haemost; 1995 Jul; 74(1):482-5. PubMed ID: 8578510
[TBL] [Abstract][Full Text] [Related]
18. Seal properties of TachoSil: in vitro hemodynamic measurements.
Berdajs D; Bürki M; Michelis A; von Segesser LK
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):910-3. PubMed ID: 20354036
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial.
Cardillo G; Carleo F; Carbone L; De Massimi AR; Lococo A; Santini PF; Janni A; Gonfiotti A
Eur J Cardiothorac Surg; 2012 Mar; 41(3):657-62. PubMed ID: 22219405
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the hemostatic potential of modern topical sealants on arterial and venous anastomoses: an experimental porcine study.
Fonouni H; Kashfi A; Majlesara A; Stahlheber O; Konstantinidis L; Kraus TW; Mehrabi A; Oweira H
J Mater Sci Mater Med; 2017 Sep; 28(9):134. PubMed ID: 28755096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
